Genesco (GCO), Daha Küçük Satışların Hala Daha Büyük Karlar Anlamına Gelebileceğini Kanıtladı

Genesco (GCO) Proves Smaller Sales Can Still Mean Bigger Profits

Sat, September 12, 2026 at 6:05 PM GMT+3 4 min read

• GCO +5.43%

On September 3, Genesco (NYSE:GCO) reported a second quarter that should not have worked on paper. Revenue fell 3% to $530 million, yet the company nearly halved its adjusted operating loss and raised full-year earnings guidance to the top end of its range. That combination, shrinking sales alongside expanding profit, is the footwear-first strategy showing up in real numbers. Every one of the company's three brands beat internal expectations, and management says the toughest sales pressure ahead is coming from a deliberate choice rather than a weakening business.

Journeys Keeps Finding New Gears

Journeys, the company's teen-focused chain, delivered its eighth consecutive quarter of positive comparable sales, up 2%, even while lapping strong growth from a year earlier. The more interesting story sits underneath that number. The Journeys 4.0 store format, a redesigned concept built around a more elevated assortment, is generating a sales lift of 25% or more wherever it opens, and the company expects roughly 180 locations, about a fifth of its fleet, running that format by year-end. That rollout, combined with fleet optimization and more efficient use of selling staff, handed Journeys 180 basis points of expense leverage in the quarter. Comparable sales kept accelerating into August, marking Journeys' ninth straight month of positive comps and a mid-single-digit gain during the back-to-school peak.

Johnston & Murphy is running its own streak, with comparable sales up 4% in its third consecutive positive quarter, helped by a newly extended, multiyear partnership with Peyton Manning and a broader shift in menswear toward more refined, put-together dressing. Companywide, adjusted gross margin expanded 140 basis points to 47.2%, and the adjusted operating loss narrowed to $8 million from $14 million a year ago. Genesco also collected $22.5 million in tariff refunds during the quarter and cut total debt to $15.8 million from $71 million a year earlier, giving a new CFO and a new Schuh president a far healthier balance sheet to work with as they settle into their roles.

The UK Problem Won't Quit

The drag comes almost entirely from Schuh, Genesco's UK chain, where comparable sales fell 9% as management deliberately pulled back on discounting to protect margin. Executives were blunt about the cost of that choice. CEO Mimi Vaughn said "the UK consumer market remains challenged and price sensitive," and the Schuh turnaround is expected to take longer than the one already underway at Journeys. That pressure is now baked into guidance. Full-year total sales are expected to fall about 2%, worse than the prior forecast of down 1% to flat, with management incorporating more back-half sales pressure than it originally planned for given how promotional the UK footwear market has become.

The near-term picture gets bumpier before it improves. Third-quarter sales are projected to fall 4% to 4.5%, hurt by a $14 million hit from exiting older licensed brands ahead of the Wrangler footwear launch, plus heavier marketing spend tied to back-to-school and the new Johnston & Murphy campaign. Operating income is expected to land moderately below last year's third quarter even as EPS improves. Genesco also finished the quarter with 1,186 stores, down 5% from a year earlier, and inventory climbed 8% to $539.7 million heading into the holiday season.

Wall Street's Mixed Signals

Hedge fund ownership of Genesco climbed to 20 funds in the most recent quarter from 15 the quarter before, a sign of building institutional conviction. Short interest tells a different story, sitting at 10.85% of the float, a level that points to a real, entrenched bear camp rather than casual skepticism. As of September 11, the stock trades at a forward price-to-earnings ratio of 13.87, a modest multiple that does not look like it is pricing in much of the earnings recovery already underway. That gap between rising fund interest and heavy short positioning suggests the market has not settled on which version of the Genesco story is right.

What Happens Next Matters Most

Genesco's second quarter showed a company that can grow profit even while sales shrink, but the next two quarters test whether that formula holds through the license transition and a tougher UK market. For Journeys and Johnston & Murphy to keep compounding, the 4.0 rollout and the Peyton Manning campaign need to keep pulling in new, younger shoppers. For Schuh, the payoff depends on whether pricing discipline in a promotional market eventually turns into sales growth rather than just fatter margins on a shrinking base.

While we acknowledge the potential of GCO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on thebest short-term AI stock.

READ NEXT: 10 Best Future Stocks to Buy Under $10 and 12 Best Performing Semiconductor Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.